1. Neuropilin-1 facilitates SARS-CoV-2 cell entry and infectivity
- Author
-
Cantuti-Castelvetri, Ludovico; https://orcid.org/0000-0002-0642-1610, Ojha, Ravi; https://orcid.org/0000-0001-7876-4607, Pedro, Liliana D; https://orcid.org/0000-0003-3556-647X, Djannatian, Minou; https://orcid.org/0000-0002-7759-6557, Franz, Jonas; https://orcid.org/0000-0001-7523-6622, Kuivanen, Suvi; https://orcid.org/0000-0002-2347-5397, van der Meer, Franziska; https://orcid.org/0000-0002-9433-9173, Kallio, Katri, Kaya, Tuğberk; https://orcid.org/0000-0001-5926-8608, Anastasina, Maria; https://orcid.org/0000-0002-4555-6446, Smura, Teemu, Levanov, Lev, Szirovicza, Leonora; https://orcid.org/0000-0003-1528-044X, Tobi, Allan; https://orcid.org/0000-0003-4797-5481, Kallio-Kokko, Hannimari, Österlund, Pamela; https://orcid.org/0000-0002-2229-6661, Joensuu, Merja; https://orcid.org/0000-0002-4533-0455, Meunier, Frédéric A; https://orcid.org/0000-0001-6400-1107, Butcher, Sarah J; https://orcid.org/0000-0001-7060-5871, Winkler, Martin Sebastian, Mollenhauer, Brit, Helenius, Ari, Gokce, Ozgun; https://orcid.org/0000-0001-6319-404X, Teesalu, Tambet; https://orcid.org/0000-0002-9458-6385, Hepojoki, Jussi; https://orcid.org/0000-0001-5699-214X, Vapalahti, Olli; https://orcid.org/0000-0003-2270-6824, Stadelmann, Christine; https://orcid.org/0000-0003-1766-5458, Balistreri, Giuseppe; https://orcid.org/0000-0002-3585-559X, Simons, Mikael; https://orcid.org/0000-0001-5329-192X, Cantuti-Castelvetri, Ludovico; https://orcid.org/0000-0002-0642-1610, Ojha, Ravi; https://orcid.org/0000-0001-7876-4607, Pedro, Liliana D; https://orcid.org/0000-0003-3556-647X, Djannatian, Minou; https://orcid.org/0000-0002-7759-6557, Franz, Jonas; https://orcid.org/0000-0001-7523-6622, Kuivanen, Suvi; https://orcid.org/0000-0002-2347-5397, van der Meer, Franziska; https://orcid.org/0000-0002-9433-9173, Kallio, Katri, Kaya, Tuğberk; https://orcid.org/0000-0001-5926-8608, Anastasina, Maria; https://orcid.org/0000-0002-4555-6446, Smura, Teemu, Levanov, Lev, Szirovicza, Leonora; https://orcid.org/0000-0003-1528-044X, Tobi, Allan; https://orcid.org/0000-0003-4797-5481, Kallio-Kokko, Hannimari, Österlund, Pamela; https://orcid.org/0000-0002-2229-6661, Joensuu, Merja; https://orcid.org/0000-0002-4533-0455, Meunier, Frédéric A; https://orcid.org/0000-0001-6400-1107, Butcher, Sarah J; https://orcid.org/0000-0001-7060-5871, Winkler, Martin Sebastian, Mollenhauer, Brit, Helenius, Ari, Gokce, Ozgun; https://orcid.org/0000-0001-6319-404X, Teesalu, Tambet; https://orcid.org/0000-0002-9458-6385, Hepojoki, Jussi; https://orcid.org/0000-0001-5699-214X, Vapalahti, Olli; https://orcid.org/0000-0003-2270-6824, Stadelmann, Christine; https://orcid.org/0000-0003-1766-5458, Balistreri, Giuseppe; https://orcid.org/0000-0002-3585-559X, and Simons, Mikael; https://orcid.org/0000-0001-5329-192X
- Abstract
The causative agent of coronavirus disease 2019 (COVID-19) is the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). For many viruses, tissue tropism is determined by the availability of virus receptors and entry cofactors on the surface of host cells. In this study, we found that neuropilin-1 (NRP1), known to bind furin-cleaved substrates, significantly potentiates SARS-CoV-2 infectivity, an effect blocked by a monoclonal blocking antibody against NRP1. A SARS-CoV-2 mutant with an altered furin cleavage site did not depend on NRP1 for infectivity. Pathological analysis of olfactory epithelium obtained from human COVID-19 autopsies revealed that SARS-CoV-2 infected NRP1-positive cells facing the nasal cavity. Our data provide insight into SARS-CoV-2 cell infectivity and define a potential target for antiviral intervention.
- Published
- 2020